Our study is one of a kind owing to measuring the serum sclerostin levels in an Egyptian homogeneous cohort of pediatric and adolescent patients with T1DM with and without DN, in comparison to healthy controls. The gene discussed is SOST; the disease is liver dysplastic nodule.